Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioCardia

2.77
+0.03001.09%
Post-market: 2.70-0.0700-2.53%18:33 EDT
Volume:85.96K
Turnover:241.29K
Market Cap:12.97M
PE:-0.96
High:2.92
Open:2.75
Low:2.71
Close:2.74
Loading ...

BioCardia Q1 EPS $(0.59) Misses $(0.39) Estimate

Benzinga
·
2 hours ago

BioCardia Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
13 May

BioCardia Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
09 May

BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing Cardiamp HF Ii Pivotal Study

THOMSON REUTERS
·
06 May

Biotech Alert: Searches spiking for these stocks today

TipRanks
·
02 May

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind Cardiamp HF Ii Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

THOMSON REUTERS
·
01 May

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

GlobeNewswire
·
01 May

BioCardia files to sell 813,636 shares of common stock for holders

TIPRANKS
·
01 May

Director Richard M. Krasno Reports Acquisition of Common Shares of BioCardia Inc

Reuters
·
29 Apr

BRIEF-Biocardia Announces Positive Dsmb Review Of Cardiallo Allogeneic Cell Therapy For Heart Failure Phase 1/2 Clinical Trial

Reuters
·
15 Apr

BioCardia’s CardiALLO Trial Advances After Safety Review

TIPRANKS
·
15 Apr

BioCardia Announces Positive Dsmb Review of Cardiallo Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial

THOMSON REUTERS
·
15 Apr

BioCardia Inc: Plans to Progress Trial to Enrollment of 39 Participants in United States

THOMSON REUTERS
·
15 Apr

BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial

GlobeNewswire
·
15 Apr

BioCardia Says Emory University Enrolling Heart Patients for CardiAMP HF II Trial

MT Newswires Live
·
12 Apr

BRIEF-Biocardia Initiates Patient Enrollment At Emory University School Of Medicine

Reuters
·
11 Apr

BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing Cardiamp HF Ii Pivotal Study

THOMSON REUTERS
·
11 Apr

BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study

GlobeNewswire
·
11 Apr

BioCardia’s Earnings Call Highlights Strong Trial Results

TIPRANKS
·
02 Apr

BioCardia Inc (BCDA) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and Promising ...

GuruFocus.com
·
01 Apr